Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
Follow MTD
Mettler-Toledo International, Inc. (MTD) Revenue
Mettler-Toledo International, Inc.'s revenue for fiscal 2025 was $4.0B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $4.1B. Over the past ten years it has ranged from $2.4B (fiscal 2015) to $4.0B (fiscal 2025) — the current reading is the highest in ten years. Mettler-Toledo International, Inc. ranks 11th of 50 Diagnostics & Research companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $4.0B | 3.98% |
| FY2024 | $3.9B | 2.22% |
| FY2023 | $3.8B | (3.35%) |
| FY2022 | $3.9B | 5.43% |
| FY2021 | $3.7B | 20.51% |
| FY2020 | $3.1B | 2.54% |
| FY2019 | $3.0B | 2.49% |
| FY2018 | $2.9B | 7.73% |
| FY2017 | $2.7B | 8.64% |
| FY2016 | $2.5B | 4.71% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $1.0B | 8.47% |
| Mar 2026 | $947.1M | (16.16%) |
| Dec 2025 | $1.1B | 9.72% |
| Sep 2025 | $1.0B | 4.73% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| IQV IQVIA Holdings Inc. compare | $17.0B |
| LH Labcorp Holdings Inc. compare | $14.3B |
| DGX Quest Diagnostics Incorporated compare | $11.6B |
| A Agilent Technologies, Inc. compare | $7.4B |
| WAT Waters Corporation compare | $4.6B |
| IDXX IDEXX Laboratories, Inc. compare | $4.6B |
| ILMN Illumina, Inc. compare | $4.5B |
| MTD Mettler-Toledo International, Inc. | $4.1B |
| GH Guardant Health, Inc. compare | $1.2B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MTD
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement